Filipino IT professional wins in Novartis international essay competition on malaria
Mr. Jennel Cheng, a 27-year-old Filipino information technology (IT) professional, is one of the grand prize winners in the Novartis “World Briefing: Telling the Malaria Story” international essay-writing contest for graduate students, which involved more than 45 entries from around the world.
Sponsored by Novartis and Malaria No More, the contest involved graduate students up to 35 years old currently enrolled at an accredited university in the United States, Argentina, Ecuador, Italy, Netherlands, Venezuela, and the Philippines. Contest participants wrote an essay in English of 500 words or less that focused on the current malaria burden and ways in which their generation can make progress in the fight against malaria.
Together with the other two winners from Belgium and the Netherlands, Cheng will travel with the Novartis team in October to Zambia, a malaria-endemic country which has successfully reduced morbidity and mortality related to malaria by over 60%.
About the contest
Research-based Swiss healthcare company Novartis and the non-governmental organization committed to ending malaria deaths in Africa, Malaria No More, organized the contest to increase awareness on the prevention and treatment of malaria, and help build the coalition to ease the global malaria burden.
The contest involved graduate students up to 35 years old currently enrolled at an accredited university in the United States, Argentina, Ecuador, Italy, Netherlands, Venezuela, and the Philippines. Contest participants wrote an essay in English of 500 words or less that focused on the current malaria burden and ways in which their generation can make progress in the fight against malaria. After reviewing entries from students all over the world, the contest sponsors selected Cheng as one of the three grand prize winners; the other two winners are from Belgium and the Netherlands.
About Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2009, the Group’s continuing operations achieved net sales of USD 44.3 billion, while approximately USD 7.5 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.
More information here.
Mr. Jennel Cheng, a 27-year-old Filipino information technology (IT) professional, is one of the grand prize winners in the Novartis “World Briefing: Telling the Malaria Story” international essay-writing contest for graduate students, which involved more than 45 entries from around the world.
Sponsored by Novartis and Malaria No More, the contest involved graduate students up to 35 years old currently enrolled at an accredited university in the United States, Argentina, Ecuador, Italy, Netherlands, Venezuela, and the Philippines. Contest participants wrote an essay in English of 500 words or less that focused on the current malaria burden and ways in which their generation can make progress in the fight against malaria.
Together with the other two winners from Belgium and the Netherlands, Cheng will travel with the Novartis team in October to Zambia, a malaria-endemic country which has successfully reduced morbidity and mortality related to malaria by over 60%.
About the contest
Research-based Swiss healthcare company Novartis and the non-governmental organization committed to ending malaria deaths in Africa, Malaria No More, organized the contest to increase awareness on the prevention and treatment of malaria, and help build the coalition to ease the global malaria burden.
The contest involved graduate students up to 35 years old currently enrolled at an accredited university in the United States, Argentina, Ecuador, Italy, Netherlands, Venezuela, and the Philippines. Contest participants wrote an essay in English of 500 words or less that focused on the current malaria burden and ways in which their generation can make progress in the fight against malaria. After reviewing entries from students all over the world, the contest sponsors selected Cheng as one of the three grand prize winners; the other two winners are from Belgium and the Netherlands.
About Novartis
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2009, the Group’s continuing operations achieved net sales of USD 44.3 billion, while approximately USD 7.5 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.
More information here.
